首页> 外文期刊>Advances in Pharmacology and Pharmacy >Comparative Studies on Solubility and Dissolution Enhancement of Different Itraconazole Salts and Their Complexes
【24h】

Comparative Studies on Solubility and Dissolution Enhancement of Different Itraconazole Salts and Their Complexes

机译:伊曲康唑盐及其配合物的溶解度和溶解度提高的比较研究

获取原文
       

摘要

Itraconazole is a potent triazole antifungal drug which has low solubility at physiological pH conditions. Itraconazole is weakly basic (pKa =3.7) and highly hydrophobic drug. It is categorized as a BCS class II drug. The main objective of the present investigation was to improve the solubility of itraconazole, by preparation of salt forms itraconazole hydrochloride, mesylate and besylate by using addition reaction with hydrochloric acid, methane sulphonic acid and benzene sulphonic acid. Further inclusion complexes of itraconazole were prepared with Captisol (sulfobutyl ether_(7) β-cyclodextrin) by using physical mixing, kneading and co-evaporation techniques. The preparations were characterized by using X-ray diffraction, Fourier Transformed Infrared spectroscopy and Nuclear Magnetic Resonance spectroscopy. The solubility of prepared salt was found multifold than the solubility of itraconazole. The dissolution studies exhibited higher percentage drug dissolution from itraconazole complexes than that of the pure drug which can be attributed to the increase in drug solubility provoked by the complexation technique.
机译:伊曲康唑是一种有效的三唑抗真菌药,在生理pH条件下溶解度低。伊曲康唑是弱碱性(pKa = 3.7)和高疏水性药物。它被归类为BCS II类药物。本研究的主要目的是通过与盐酸,甲烷磺酸和苯磺酸加成反应制备盐形式的伊曲康唑盐酸盐,甲磺酸盐和苯磺酸盐,从而提高伊曲康唑的溶解度。通过物理混合,捏合和共蒸发技术,用Captisol(磺丁基醚_(7)β-环糊精)制备了伊曲康唑的其他包合物。通过使用X射线衍射,傅立叶变换红外光谱和核磁共振光谱对制剂进行表征。发现制备的盐的溶解度是伊曲康唑的溶解度的数倍。溶出度研究显示,伊曲康唑复合物比纯药物具有更高的溶出度,这可以归因于络合技术引起的药物溶解度的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号